documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

19 rows where docket_id = "FDA-2004-E-0269" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 4

document_type 3

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-E-0269-0019 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Morgan Lewis & Bockius, LLP Rule Certificate Extending Patent Term 2007-04-20T04:00:00Z 2007 4     2025-11-18T19:18:37Z   0 0 090000648047220a
FDA-2004-E-0269-0018 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Notice of Final Determination from U.S. Patent and Trademark Office to Morgan Lewis & Bockius, LLP Other Letter(s) 2007-02-06T05:00:00Z 2007 2     2025-11-18T19:16:52Z   0 0 0900006480472209
FDA-2004-E-0269-0017 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Letter from FDA CDER to the U.S. Patent and Trademark Office Other Letter(s) 2006-09-08T04:00:00Z 2006 9     2025-11-18T19:13:09Z   0 0 0900006480472208
FDA-2004-E-0269-0016 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Letter from U.S. Patent and Trademark Office and FDA CDER Other Letter(s) 2006-06-20T04:00:00Z 2006 6     2025-11-18T19:09:15Z   0 0 0900006480472207
FDA-2004-E-0269-0015 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Determination of Regulatory Review Period for Purposes of Patent Extension; SURPASS Notice General Notice 2006-02-15T05:00:00Z 2006 2 2006-02-03T05:00:00Z   2025-11-18T19:06:04Z E6-1434 0 0 0900006480472206
FDA-2004-E-0269-0014 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-01-11T05:00:00Z 2006 1     2025-11-18T18:59:52Z   0 0 0900006480472205
FDA-2004-E-0269-0013 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2005-04-19T04:00:00Z 2005 4     2025-11-18T18:57:34Z   0 0 0900006480472204
FDA-2004-E-0269-0002 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:07:20Z   0 0 09000064804721f9
FDA-2004-E-0269-0005 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:14:54Z   0 0 09000064804721fc
FDA-2004-E-0269-0010 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:26:27Z   0 0 0900006480472201
FDA-2004-E-0269-0009 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:24:06Z   0 0 0900006480472200
FDA-2004-E-0269-0007 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:19:50Z   0 0 09000064804721fe
FDA-2004-E-0269-0004 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:12:39Z   0 0 09000064804721fb
FDA-2004-E-0269-0008 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:21:57Z   0 0 09000064804721ff
FDA-2004-E-0269-0006 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:16:45Z   0 0 09000064804721fd
FDA-2004-E-0269-0001 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T18:50:56Z   0 0 09000064804721f7
FDA-2004-E-0269-0011 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:30:34Z   0 0 0900006480472202
FDA-2004-E-0269-0003 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Letter(s) 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:09:28Z   0 0 09000064804721fa
FDA-2004-E-0269-0012 FDA Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078 FDA-2004-E-0269 Duplicate - Application for Patent Term Extension from Mezei Associates, Ltd. Other Application 2004-09-01T04:00:00Z 2004 9     2025-11-18T20:31:58Z   0 0 0900006480472203

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);